Antibody Discovery Market 2024 - By Size, Competitive Landscape, Upcoming Trends And Outlook By 2033

The Business Research Company recently released a comprehensive report on the Global Antibody Discovery Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The antibody discovery market size has grown rapidly in recent years. It will grow from $8.09 billion in 2023 to $8.96 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to surge in investment for drug discovery, growing investment in research and development activities, and presence of various healthcare research centers and academic institutions.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Market Drivers and Trends:

The growing need for precision therapeutics is expected to propel the growth of the antibody discovery market going forward. Precision therapeutics, also known as personalized therapeutics, refers to the customization of medical treatment plans and interventions to the individual characteristics of each patient. Antibody discovery is used in precision therapeutics, enabling the development of targeted therapies, such as monoclonal antibodies, designed to interact with disease-related molecules or cells specifically and precisely for more effective and personalized treatment. For instance, in January 2023, according to the Personalized Medicine Coalition, a US-based professional membership organization, the Food and Drug Administration's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022 and out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized medicines by the Personalized Medicine Coalition (PMC). Therefore, the growing need for precision therapeutics will drive the growth of the antibody discovery market.

Major companies operating in the antibody discovery market are developing innovative technologies, such as an AI-based computational antibody drug discovery platform, to improve the efficiency and precision of antibody development. An AI-based computational antibody drug discovery platform utilizes artificial intelligence and computational techniques to expedite the identification and optimization of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based company developing recombinant proteins from a specialized plant-based system, introduced an AI-driven antibody discovery platform. This innovative tool combines artificial intelligence, big data, machine learning, and phage display techniques to rapidly predict high-specificity and high-affinity antibody-antigen binding. This approach, akin to natural language processing, generates diverse antibody variations, enabling SwiftPharma to create comprehensive antibody libraries efficiently. This advanced system accelerates the discovery of potential antibody drugs with unprecedented speed.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

Major Key Players of the Market:

Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation , WuXi Biologics, Genmab A/S, Evotec, Cambrex corporation, ChemPartner, Aragen life science pvt ltd, Genscript Technology Corporation, Biocytogen, Alcami corporation.Inc, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A, Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio technologies , ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

Antibody Discovery Market 2024 Key Insights:

• The antibody discovery market is expected to grow to $13.21 billion in 2028 at a compound annual growth rate (CAGR) of 10.2%.
• Antibody Discovery Market Fueled By Rising Demand For Precision Therapeutics
• AI-Powered Platforms Revolutionize Therapeutic Development
• North America was the largest region in the antibody discovery market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13783&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.